司会のことば
清 島 満*1 橋 本 磨*2
Clinical Practice Guidelines for Major Diseases－Chairmen’s Remarks
Mitsuru SEISHIMA, MD*1 and Takuma HASHIMOTO*2, MD
The number of patients with life-style related diseases is now markedly increasing in Japan. To prevent the increase in such patients, it is critical to diagnose and, if necessary, to treat patients according to evidence-based medicine. Recently, many clinical practice guidelines have been released from specialty societies in Japan. In this session, the guidelines for hyperlipidemia, hypertension, diabetes mellitus(DM) and endocrine diseases except DM are outlined by the expert. These guidelines reflect current evidence and should be used to formulate a strategy that suits the individual patient's needs.
[Rinsho Byori 51 : 574～575, 2003]
*1Department of Clinical Laboratory Medicine, Gifu University School of Medicine, Gifu 500-8705
*2Department of Laboratory Medicine, Kanazawa University School of Medicine, Kanazawa 920-8640
【Key Words】clinical practice guideline(診療ガイドライン)，hyperlipidemia(高脂血症)，hypertension(高血圧症)，diabetes mellitus(糖尿病)，endocrine diseases(内分泌疾患)
*1岐阜大学医学部総合病態・予防医学臨床検査医学分野(〒500-8705 岐阜市司町40)
*2金沢大学医学部血液情報統御学(〒920-8640 金沢市宝町13-1)
E-mail :seishima@cc.gifu-u.ac.jp